KKM Say No To Ivermectin for Covid-19 Treatment after Study - Ivermectin Treatment Efficacy In Covid-19 High Risk Patient

Rabu, 03 November 2021

data-original-width="828" height="848" src="https://blogger.googleusercontent.com/img/a/AVvXsEiX8NSmUnwolkDNVxQ80WHHFRj8axf_lv6RDlE9VbP_CMz5voKZdZ_44yWTvJgXp6VZ71_n5JAXFjv7Fw3VUO54lki75kwfYoV78Xt9gUhtKfx8MSv7SeKfGPP7EtsjulH3--LSvxB8AkkEQnwbeUXca0C0SxFwWn-cy0T2cq70lrfsBYHOlcYMbTdQRw=w602-h848" width="602">

Media statement Ministry of Health Malaysia

Based on the outcomes of the I-TECH study, ivermectin cannot be recommended for inclusion in current COVID-19 treatment guidelines as ivermectin does not reduce risk of severe illness from COVID-19.#ivermectin #COVID19 pic.twitter.com/HH3koAIhsP
— KKMalaysia🇲🇾 (@KKMPutrajaya) November 3, 2021